Arkolith/Insider Trading/SMMT/Form 4

Zanganeh Mahkam

Chief Executive Officer, DirectorSummit Therapeutics Inc. (SMMT) · full profile →Form 4 · filed Aug 23, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
0 non-derivative · 3 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 23, 2024Grant(A)100K——100K
Aug 23, 2024Grant(A)2.4M——2.4M
Aug 23, 2024Grant(A)260K——260K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001599298-24-000123) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML